Latest Press Releases
View all
TimeHeadline
7h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
8h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
10h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
18h agoBuffalo Potash Files Annual Information Form and New Technical Report
19h agoIonik Announces 30-Day Extension of Senior Debt Facility
Formycon Ag logo

Formycon Ag

About

20.05EUR+0.39 +1.98%
Closed • Updated at 21:35 GMT+00:00
Market Cap$411.61M
Volume19.0K
Beta1.64
RSI56.63
Gross Margin8.04%
Health TechnologyPharmaceuticals: Major

Formycon Ag — investor relations, events, news, and company updates on 6ix.

Latest News

Dec 23 2025
Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO®, an Interchangeable Biosimilar to Lucentis®
Dec 9 2025
Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda® (Pembrolizumab), in the U.S. and Canada
Dec 4 2025
Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda® biosimilar candidate FYB206 for the MENA Region
Oct 21 2025
Polpharma Biologics announces commercial launch of Europe’s first Pre-filled Syringe presentation of a ranibizumab biosimilar
Jul 30 2025
Formycon Invites to Conference Call on 2025 Half-year Results and Announces Participation in International Investor Conferences in the 3rd Quarter of 2025

Community Chat

Ask AI

Try asking
6ix6ixAIEvents